Healthcare Information Technology
White Papers, Case Studies, and eBooks
Articles and Blog Posts
All processes—no matter how well-organized—contain some degree of waste. Toyota realized in the 1920s that manufacturing process waste—in the form of excess inventory, defective products and extraneous process steps—was the enemy of optimal manufacturing time and cost. These realizations led to the creation of the Toyota Production System (TPS), an approach that catapulted Toyota to the top of the global automotive industry. The production system was deemed the primary reason for Toyota’s success and its unparalleled quality.
Read our latest case study to learn why, when it comes to selecting a trusted component supplier, it’s crucial to partner with a company that is ISO 22301-certified, implements an effective inventory management system and has years of industry experience.
Supply chain breakdowns in product quality, delivery or availability are major disruptions in the medical device supply industry. The importance of ensuring that the supply chain is running smoothly is obvious. Providing the best possible service without interruption takes precedence over all other considerations.
This white paper discusses how partnering with a value-based and ISO-certified supplier like Qosina can ensure supply chain resiliency, technical quality and cost efficiency.
The high stress of an emergency room or ICU creates an environment where the probability of human error spikes dramatically, adding a layer of risk to an already-tense situation. Asking medical professionals to make rapid diagnoses and decisions in that stress-filled state can lead to device misconnection. To that end, ISO 80369 was written to improve patient safety and reduce the risk of small-bore misconnections used in liquid and gas healthcare applications such as enteral, neuraxial and intravascular/hypodermic, among others.
In this case study, you’ll learn how McLaren Health Care in Grand Blanc, MI successfully implemented ENFitTM, the ISO 80369-3 compliant enteral connectors, with minimal disruption in their supply chain. They executed their strategy in phases:
- Phase 1 — changing over tube feeding sets
- Phase 2 — medically administered implements — this phase was delayed due to the FDA approval process, but McLaren began including communication about the changeover in meeting agendas to prep the facilities for the coming shift
- Phase 3 — implanted and non-implanted tubes